ACC.26
Powerful Medical presented at ACC.26, sharing new data on AI-powered ECG interpretation and OMI detection with the general cardiology community, and used the meeting for focused conversations with key opinion leaders.
New Orleans, Louisiana, USA
March 28–30, 2026
ACC's Annual Scientific Session & Expo is one of the most prominent global meetings in cardiology. The 75th edition brought thousands of cardiovascular professionals from around the world to New Orleans for late-breaking clinical trials, ACC/AHA guideline updates and hundreds of educational sessions across 11 learning pathways — spanning coronary and structural intervention, electrophysiology, imaging, heart failure, prevention and digital health.
ACC.26 also featured immersive learning formats such as the Personalized Skills Zone and simulation stations, "Meet the Trialists" and "Meet the Experts" sessions, the STEMI Smackdown competition, and an AI Intensive exploring the practical implementation of AI in patient care. A large scientific and industry expo showcased emerging devices, imaging technologies and digital tools.
- Venue: Ernest N. Morial Convention Center, 900 Convention Center Blvd, New Orleans, Louisiana, USA
- Organiser: American College of Cardiology (ACC)
- Website: accscientificsession.acc.org
Share this article
About PMcardio
PMcardio features FDA-authorized and CE-marked AI ECG models that interpret any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.